Treatment option approaches to the management of chronic total occlusions

Shigeru Saito1

  • 1Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, 247-8533, Japan, cto.expert@gmail.com.

Insights

This case study discusses treatment options for severe effort angina in a patient with prior coronary artery bypass graft (CABG) surgery. Percutaneous coronary intervention (PCI) is proposed for chronic total occlusion of the native right coronary artery (RCA).

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • A 67-year-year-old patient presents with severe effort angina refractory to medical management.
  • The patient has a history of coronary artery bypass graft (CABG) surgery over 10 years prior.
  • Graft occlusion (saphenous vein graft [SVG] to right coronary artery [RCA] and SVG to circumflex artery) is noted, with a patent left internal mammary artery graft to the left anterior descending artery.

Purpose of the Study:

  • To evaluate treatment strategies for patients with severe angina and complex coronary artery disease.
  • To consider options for managing chronic total occlusion (CTO) of the native right coronary artery (RCA) in a patient with failed bypass grafts.

Main Methods:

  • Review of treatment options including repeat coronary artery bypass graft (redo CABG) versus percutaneous coronary intervention (PCI).
  • Focus on percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) of the native right coronary artery (RCA).

Main Results:

  • The patient's native RCA has been occluded since before the initial CABG surgery.
  • Previous SVG grafts to the RCA and circumflex artery have occluded.
  • The left internal mammary artery (LIMA) graft to the left anterior descending (LAD) artery remains patent.

Conclusions:

  • Percutaneous coronary intervention (PCI) is proposed as a viable treatment option for chronic total occlusion (CTO) of the native right coronary artery (RCA) in this complex patient.
  • This approach offers an alternative to redo CABG in select cases of refractory angina with CTO.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation